AstraZeneca Current Ratio 2006-2018 | AZN

Current and historical current ratio for AstraZeneca (AZN) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. AstraZeneca current ratio for the three months ending September 30, 2018 was 0.86.
AstraZeneca Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $13.11B $15.25B 0.86
2018-06-30 $12.45B $17.20B 0.72
2018-03-31 $13.18B $18.16B 0.73
2017-12-31 $13.15B $16.38B 0.80
2017-09-30 $13.63B $14.46B 0.94
2017-06-30 $14.30B $15.66B 0.91
2017-03-31 $11.64B $15.43B 0.75
2016-12-31 $13.26B $15.26B 0.87
2016-09-30 $12.87B $15.38B 0.84
2016-06-30 $13.32B $14.34B 0.93
2016-03-31 $12.77B $15.93B 0.80
2015-12-31 $16.01B $14.87B 1.08
2015-09-30 $13.20B $16.04B 0.82
2015-06-30 $13.81B $16.15B 0.86
2015-03-31 $12.69B $15.76B 0.81
2014-12-31 $16.70B $17.33B 0.96
2014-09-30 $15.07B $15.82B 0.95
2014-06-30 $16.20B $16.32B 0.99
2014-03-31 $16.54B $17.51B 0.95
2013-12-31 $20.34B $16.05B 1.27
2013-09-30 $18.79B $14.68B 1.28
2013-06-30 $19.39B $15.20B 1.28
2013-03-31 $18.34B $13.86B 1.32
2012-12-31 $19.05B $13.90B 1.37
2012-09-30 $18.03B $14.13B 1.28
2012-06-30 $19.78B $14.80B 1.34
2012-03-31 $21.56B $15.80B 1.37
2011-12-31 $23.51B $15.75B 1.49
2011-09-30 $22.47B $14.66B 1.53
2011-06-30 $22.69B $13.84B 1.64
2011-03-31 $23.47B $16.02B 1.47
2010-12-31 $25.13B $16.79B 1.50
2010-09-30 $24.57B $16.85B 1.46
2010-06-30 $23.38B $16.30B 1.43
2010-03-31 $22.35B $16.99B 1.32
2009-12-31 $23.76B $17.64B 1.35
2009-09-30 $20.54B $15.12B 1.36
2009-06-30 $19.13B $15.14B 1.26
2009-03-31 $15.85B $14.05B 1.13
2008-12-31 $16.15B $13.32B 1.21
2008-09-30 $15.60B $14.38B 1.09
2008-06-30 $16.59B $15.99B 1.04
2008-03-31 $14.69B $15.68B 0.94
2007-12-31 $17.08B $15.19B 1.13
2007-09-30 $0.00B $0.00B 0.00
2007-06-30 $16.08B $24.93B 0.65
2007-03-31 $16.29B $10.35B 1.57
2006-12-31 $16.94B $9.45B 1.79
2006-09-30 $14.43B $8.09B 1.78
2006-06-30 $15.05B $8.41B 1.79
2006-03-31 $13.51B $7.14B 1.89
2005-12-31 $13.77B $6.84B 2.01
2005-09-30 $13.10B $6.74B 1.94
2005-06-30 $13.44B $6.80B 1.98
2005-03-31 $12.70B $6.84B 1.86
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.577B $22.465B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $350.628B 16.44
Pfizer (PFE) United States $253.175B 14.27
Novartis AG (NVS) Switzerland $205.567B 17.62
Merck (MRK) United States $204.560B 17.73
AbbVie (ABBV) United States $134.627B 11.95
Eli Lilly (LLY) United States $123.506B 21.71
Novo Nordisk (NVO) Denmark $117.412B 19.07
Sanofi (SNY) France $104.035B 12.88
GlaxoSmithKline (GSK) United Kingdom $96.892B 13.02
Bristol-Myers Squibb (BMY) United States $81.806B 13.47